HealthQuill IgAN
Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of patients with a rare type of kidney disease.
Drugs Health Pharma

Novartis’s drug to treat rare kidney disease gets USFDA approval 

Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of.

Read More